http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-1107652-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a8e49a2b5f6d0ba32839687472b3a437 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-495 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D215-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-04 |
| filingDate | 1966-01-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1968-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | GB-1107652-A |
| titleOfInvention | Pharmaceutical compositions having oxytoxic activity |
| abstract | 1 - (2 - Quinolyl) - piperazine is prepared by reacting a 2-haloquinoline with piperazine, e.g. in toluene. Its salts, e.g. the maleate, are prepared by direct reaction with the acid.ALSO:Pharmaceutical compositions having oxytocic activity comprise 1-(2-quinolyl)-piperazine or a salt thereof, e.g. the maleate. They may be in conventional forms, e.g. a syrup, elixir, solid composition or injectable solution. |
| priorityDate | 1965-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 22.